May 15, 2017 - Eli Lilly and Company (LLY) recently announced that its migraine candidate, galcanezumab, met primary endpoint in phase III studies
May 15, 2017 - Teva reported a strong first quarter. Company on track to launch many new products this year. Management simultaneously cutting debt and maintaining dividend rate.
May 12, 2017 - Francis Chou Buys Endo International PLC, Teva Pharmaceutical Industries, Valeant Pharmaceuticals International Inc, Sells Nokia Oyj, AstraZeneca PLC, GlaxoSmithKline PLC, Stocks: VRX,SD,SD,ENDP,TEVA,NOK,AZN,GSK,, release date:May 12, 2017
May 12, 2017 - Teva's Women's Health operations and its European oncology and pain divisions appear to be on the chopping block.
May 12, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) reported first-quarter 2017 earnings of $1.03 per share (including equity compensation expenses), which was in line with the Zacks Consensus Estimate.
May 12, 2017 - While companies like Mylan (MYL), Allergan and Teva reported Q1 results this week, several companies provided updates on their cancer drugs.
May 12, 2017 - Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Q1 2017 Results Earnings Conference Call May 11, 2017 08:00 AM ET Executives Kevin Mannix - SVP and Head of IR Sol Barer - Chairman Yitzhak Peterburg -
May 11, 2017 - During its Q1 earnings call, Teva Pharmaceutical Industries (TEVA +1.9%) interim CEO Yitzhak Peterburg confirmed that the company intends to shop its women's heath and European oncology and pain busin
May 11, 2017 - The specialty and generic drugmaker gets another boost from its 2016 purchase of Actavis Generics from Allergan.
May 11, 2017 - Impax Laboratories Inc. (IPXL) posted first-quarter 2017 adjusted earnings of 11 cents per share, missing the Zacks Consensus Estimate of 12 cents. Earnings were down 74.4% from 43 cents in the year-ago period